FDA Approves Lipfendra Pill That Cuts LDL by More Than 50%
Updated
Updated · WTVD-TV · Jul 25
FDA Approves Lipfendra Pill That Cuts LDL by More Than 50%
3 articles · Updated · WTVD-TV · Jul 25
Summary
Lipfendra won FDA approval last week as the first pill in a potent cholesterol-lowering drug class previously available only by injection, with pharmacies expected to receive it in coming weeks.
Clinical trials showed the daily pill lowered LDL cholesterol by more than 50% in most patients, delivering results doctors said were similar to injectable versions.
Doctors say the oral option could widen access by removing needles and potentially lowering list prices, though patients' actual costs will still depend on insurance coverage.
The drug is aimed at patients whose cholesterol remains uncontrolled on statins or who cannot tolerate statin side effects, rather than replacing statins for everyone.